Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Gemcitabine + Cisplatin in MPM
NCT01243632Phase 2Completed
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Dec 2002
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in malignant pleural mesothelioma (MPM), sponsored by Institute of Oncology Ljubljana. Started Dec 2002; status: completed.
02
Drugs
gemcitabine
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01243632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243632.